Department of Medicine Archives
An unexpected side effect of public health education efforts in Brazil
Mar. 20, 2018—Understanding of tuberculosis is associated with higher, not lower, stigmatization of TB patients in Brazil, according to a new report from Vanderbilt’s Latin American Public Opinion Project.
Study spots undiagnosed genetic diseases in EHR
Mar. 15, 2018—Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.
Research explores barriers to kidney disease screening
Mar. 15, 2018—New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.
Cancer immunotherapy drugs linked with more serious heart effects
Mar. 12, 2018—Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.
Lovly earns scholarship grant for lung cancer research
Mar. 8, 2018—Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer.
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Mar. 6, 2018—Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).
Saline use on decline at Vanderbilt following landmark studies
Feb. 27, 2018—Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.
Schlendorf named adult heart transplant medical director
Feb. 15, 2018—Kelly Schlendorf, MD, MHS, assistant professor of Medicine, has been named medical director of Vanderbilt University Medical Center’s (VUMC) Adult Heart Transplant Program.
Protecting transplanted lungs
Feb. 12, 2018—Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered.
Study seeks to boost breast tumor immune response
Feb. 8, 2018—Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.
AIDS-defining events increase mortality risk: study
Feb. 8, 2018—When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs.
Study tracks therapy to slow idiopathic pulmonary fibrosis
Feb. 1, 2018—Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.